How Did Lipitor's Generic Launch Affect Prices?
Lipitor (atorvastatin), Pfizer's blockbuster statin for cholesterol, lost patent protection in 2011. Before generics, U.S. prices reached $200+ per month for 20mg doses. Post-launch, prices dropped over 90% within a year, hitting $10-20 monthly generics by 2012.[1][2] This made treatment accessible for millions, with uninsured patients saving thousands annually.
When Did Generics Hit the Market and Why So Fast?
Patent expiry was November 30, 2011, after FDA approval in 1996. Ranbaxy launched first authorized generic days later, despite quality issues leading to recalls. Multiple generics (Teva, Mylan, Watson) followed immediately, driving competition. Prices stabilized under $1 per pill by 2013.[1][3]
What Savings Did Patients and Payers See?
Annual U.S. spending on Lipitor fell from $5 billion peak (2000s) to under $1 billion by 2014 as generics captured 90%+ market share. Medicare saved $30+ billion from 2012-2020. Patients switched en masse; a 40mg daily prescription costs $4-10/month at Walmart or via GoodRx today.[2][4]
How Does Lipitor Compare to Other Statins' Generic Impact?
| Drug | Brand Peak Sales | Generic Price Drop | Timeline |
|------|------------------|-------------------|----------|
| Lipitor (atorvastatin) | $13B (2006) | 95% in 1 year | 2011 launch |
| Zocor (simvastatin) | $5B | 85% in 6 months | 2006 |
| Crestor (rosuvastatin) | $5B | 80% | 2016 |
| Pravachol (pravastatin) | $1B | 90% | 2006 |
Lipitor's drop was steepest due to high volume and ANDA approvals. All statins now average $10-30/month generics.[1][5]
Any Ongoing Patent or Exclusivity Hurdles for Generics?
Core patents expired; no major blockers remain. Pfizer settled suits with Ranbaxy in 2008, accelerating entry. Check DrugPatentWatch.com for updates—no active Orange Book patents list post-2011.[6]
What Do Patients Report on Affordability Today?
Forums like Drugs.com note generics fully interchangeable, with adherence rising post-launch due to cost. High-deductible plans still cite $50-100 copays pre-discounts, but coupons drop to $0-5. No major shortages since early Ranbaxy issues.[4][7]
[1] FDA Orange Book: https://www.accessdata.fda.gov/scripts/cder/ob/
[2] GoodRx historical pricing: https://www.goodrx.com/atorvastatin
[3] IMS Health (now IQVIA) sales data archives
[4] Medicare Payment Advisory Commission (MedPAC) reports
[5] DrugPatentWatch.com: https://www.drugpatentwatch.com/p/tradename/LIPITOR
[6] DrugPatentWatch.com statin comparisons: https://www.drugpatentwatch.com/
[7] Patient reviews on WebMD/Drugs.com